{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:29Z","timestamp":1787041649840,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015920","name":"Guangxi University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019042","name":"Jiangsu Ocean University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119073","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:34:54Z","timestamp":1781739294000},"page":"119073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of novel N-(alkylpiperidinyl) substituted benzamides targeting the glycine transporter 2 with anti-nociceptive effects in neuropathic pain"],"prefix":"10.1016","volume":"317","author":[{"given":"Xingyu","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0117-3462","authenticated-orcid":false,"given":"Wenjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2826-4281","authenticated-orcid":false,"given":"Tao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119073_bib1","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","article-title":"Chronic pain: an update on burden, best practices, and new advances","volume":"397","author":"Cohen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.119073_bib2","first-page":"199","article-title":"Pain-resolving immune mechanisms in neuropathic pain","volume":"19","author":"Fiore","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2026.119073_bib3","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1097\/j.pain.0000000000001824","article-title":"Neuropathic pain in the community: prevalence, impact, and risk factors","volume":"161","author":"Smith","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2026.119073_bib4","article-title":"Developmental approaches to chronic pain: a narrative review","volume":"15","author":"Patel","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2026.119073_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2174\/1570159X19666210609161447","article-title":"Depression and pain: use of antidepressants","volume":"20","author":"Bonilla-Jaime","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bja.2021.08.032","article-title":"Selective serotonin reuptake inhibitors and serotonin\u2013norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials","volume":"128","author":"Wang","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejmech.2026.119073_bib7","article-title":"Pregabalin and gabapentin for pain","volume":"369","author":"Mathieson","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2026.119073_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108546","article-title":"Neuropathic pain: from actual pharmacological treatments to new therapeutic horizons","volume":"251","author":"Thouaye","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119073_bib9","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI70026","article-title":"A feed-forward spinal cord glycinergic neural circuit gates mechanical allodynia","volume":"123","author":"Lu","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119073_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/biom11060846","article-title":"Glycine receptors in spinal nociceptive control\u2014an update","volume":"11","author":"Zeilhofer","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119073_bib11","doi-asserted-by":"crossref","DOI":"10.1042\/NS20160009","article-title":"Glycinergic transmission: glycine transporter GlyT2 in neuronal pathologies","volume":"1","author":"Zafra","year":"2017","journal-title":"Neuronal Signal"},{"key":"10.1016\/j.ejmech.2026.119073_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainresbull.2019.07.008","article-title":"Glycine transporter inhibitors: a new avenue for managing neuropathic pain","volume":"152","author":"Al-Khrasani","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejmech.2026.119073_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11916-017-0629-5","article-title":"Neuropathic pain: central vs. peripheral mechanisms","volume":"21","author":"Meacham","year":"2017","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ejmech.2026.119073_bib14","first-page":"389","article-title":"Recent advances in glycine transporter 2 inhibitors for the treatment of neuropathic pain","volume":"35","author":"Li","year":"2025","journal-title":"Chin. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119073_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/srep37104","article-title":"Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain","volume":"6","author":"Imlach","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119073_bib16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41583-021-00468-2","article-title":"Neocortical circuits in pain and pain relief","volume":"22","author":"Tan","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119073_bib17","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1113\/jphysiol.2010.188292","article-title":"Glycinergic and GABAergic tonic inhibition fine tune inhibitory control in regionally distinct subpopulations of dorsal horn neurons","volume":"588","author":"Takazawa","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2026.119073_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.848642","article-title":"Glycine receptor subtypes and their roles in nociception and chronic pain","volume":"15","author":"San Mart\u00edn","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119073_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-319-55769-4_2","article-title":"Glycine transporters in glia cells: structural studies","volume":"16","author":"L\u00f3pez-Corcuera","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.ejmech.2026.119073_bib20","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.cell.2024.02.026","article-title":"Transport mechanism and pharmacology of the human GlyT1","volume":"187","author":"Wei","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119073_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1085\/jgp.201912318","article-title":"A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2","volume":"151","author":"Erdem","year":"2019","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejmech.2026.119073_bib22","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/bph.14189","article-title":"Activity of novel lipid glycine transporter inhibitors on synaptic signalling in the dorsal horn of the spinal cord","volume":"175","author":"Winters","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuint.2013.08.012","article-title":"Lipid inhibitors of high affinity glycine transporters: identification of a novel class of analgesics","volume":"73","author":"Carland","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2026.119073_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2014.05.006","article-title":"Glycine transport inhibitors for the treatment of pain","volume":"35","author":"Vandenberg","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119073_bib25","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1021\/acs.jmedchem.7b00956","article-title":"Modulation of glycine-mediated spinal neurotransmission for the treatment of chronic pain","volume":"61","author":"Cioffi","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119073_bib26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/biom11060864","article-title":"Inhibition of glycine re-uptake: a potential approach for treating pain by augmenting glycine-mediated spinal neurotransmission and blunting central nociceptive signaling","volume":"11","author":"Cioffi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.119073_bib27","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3390\/ijms22052479","article-title":"Pharmacological evidence on augmented antiallodynia following systemic co-treatment with GlyT-1 and GlyT-2 inhibitors in rat neuropathic pain model","volume":"22","author":"Mohammadzadeh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119073_bib28","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acs.jmedchem.8b01775","article-title":"Development of an N-acyl amino acid that selectively inhibits the glycine transporter 2 to produce analgesia in a rat model of chronic pain","volume":"62","author":"Mostyn","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119073_bib29","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1021\/acschemneuro.0c00602","article-title":"Structural determinants of the neuronal glycine transporter 2 for the selective inhibitors ALX1393 and ORG25543","volume":"12","author":"Benito-Mu\u00f1oz","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119073_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1213\/ANE.0b013e3181c7ebbb","article-title":"The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model","volume":"110","author":"Haranishi","year":"2010","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejmech.2026.119073_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pbb.2015.01.001","article-title":"Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain","volume":"130","author":"Takahashi","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2026.119073_bib32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/bph.12343","article-title":"Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain","volume":"170","author":"Mingorance-Le Meur","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jphs.2015.02.010","article-title":"Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain","volume":"127","author":"Omori","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.119073_bib34","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1016\/j.bmcl.2014.06.059","article-title":"The discovery of potent glycine transporter type-2 inhibitors: design and synthesis of phenoxymethylbenzamide derivatives","volume":"24","author":"Takahashi","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119073_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jcph.973","article-title":"Safety, tolerability, and pharmacokinetic characteristics of a novel nonopioid analgesic, VVZ-149 injections in healthy volunteers: a first-in-class, first-in-human study","volume":"58","author":"Oh","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011035","article-title":"Randomised, double-blind, parallel group, placebo-controlled study to evaluate the analgesic efficacy and safety of VVZ-149 injections for postoperative pain following laparoscopic colorectal surgery","volume":"7","author":"Nedeljkovic","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejmech.2026.119073_bib37","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1021\/acschemneuro.3c00167","article-title":"Novel phenylene lipids that are positive allosteric modulators of glycine receptors and inhibitors of glycine transporter 2","volume":"14","author":"Gallagher","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2026.119073_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112144","article-title":"Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and \u03bc-opioid receptor agonists for treating neuropathic pain","volume":"191","author":"Xiong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119073_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175870","article-title":"Pregabalin can interact synergistically with Kv7 channel openers to exert antinociception in mice","volume":"954","author":"Huang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177919","article-title":"Discovery of two new co-drugs of celecoxib and gabapentinoids for treating chemotherapy-induced peripheral neuropathy","volume":"1003","author":"Yin","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107921","article-title":"Benzylpiperidine derivatives as new dual \u03bc-opioid and \u03c31 receptor ligands with potent antinociceptive effects","volume":"153","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119073_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114649","article-title":"Benzylaminofentanyl derivates: discovery of bifunctional \u03bc opioid and \u03c31 receptor ligands as novel analgesics with reduced adverse effects","volume":"241","author":"Zhuang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119073_bib43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.mcb.2021.12.019","article-title":"Methods and protocols for chemotherapy-induced peripheral neuropathy (CIPN) mouse models using paclitaxel","volume":"168","author":"Pennypacker","year":"2022","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119073_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176738","article-title":"The synergistic anti-nociceptive effects of nefopam and gabapentinoids in inflammatory, osteoarthritis, and neuropathic pain mouse models","volume":"977","author":"Xiao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.108.136267","article-title":"Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice","volume":"326","author":"Morita","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2026.119073_bib46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/bph.12343","article-title":"Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain","volume":"170","author":"Mingorance-Le Meur","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119073_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acsmedchemlett.4c00529","article-title":"Discovery of novel pH-sensitive \u03bc-opioid receptor agonists as potent analgesics with reduced side effects","volume":"16","author":"Wang","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119073_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2025.100099","article-title":"Discovery of a long-acting nanocrystal formulation of INND-2201, a new co-drug of pregabalin and palmitoylethanolamide with synergistic analgesic effects","volume":"3","author":"Han","year":"2025","journal-title":"Pharm. Sci. Adv."},{"key":"10.1016\/j.ejmech.2026.119073_bib49","article-title":"Mechanisms of transport and analgesic compounds recognition by glycine transporter 2","volume":"122","author":"Wang","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119073_bib50","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.cell.2024.02.026","article-title":"Transport mechanism and pharmacology of the human GlyT1","volume":"187","author":"Wei","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119073_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119073_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118616","article-title":"Discovery of 3-indolealkylamines as novel dual-target \u03c31R\/H3R ligands with potent analgesia","volume":"306","author":"Chen","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119073_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbamem.2013.04.028","article-title":"Surface plasmon resonance spectroscopy for characterisation of membrane protein\u2013ligand interactions and its potential for drug discovery","volume":"1838","author":"Patching","year":"2014","journal-title":"BBA-Biomembranes"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:02:05Z","timestamp":1787040125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"alternative-id":["S0223523426005180"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119073","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel N-(alkylpiperidinyl) substituted benzamides targeting the glycine transporter 2 with anti-nociceptive effects in neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119073"}}